Delirium in advanced cancer patients

Palliative Medicine

Volumn 18, Issue 3, 2004, Pages 184-194

  Centeno, Carlos ^a   Sanz, Álvaro ^b   Bruera, Eduardo ^c  

^a Hospital Los Montalvos   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer; Cognition; Dehydration; Delirium; Opioid adverse effects; Palliative care

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; CHLORPROMAZINE; CIMETIDINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DRUG METABOLITE; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; METHYLPHENIDATE; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; OPIATE; PHENOBARBITAL; PROPOFOL; PSYCHOTROPIC AGENT; QUINOLONE; QUINOLONE DERIVATIVE; RANITIDINE; RISPERIDONE; UNINDEXED DRUG;

ADVANCED CANCER; ATTENTION; CANCER PATIENT; COGNITIVE DEFECT; CONFUSION; CONSCIOUSNESS DISORDER; DELIRIUM; DISEASE COURSE; DISEASE EXACERBATION; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HALF LIFE; DRUG WITHDRAWAL; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; FAMILY COUNSELING; HOSPICE; HOSPITAL ADMISSION; HUMAN; HYDRATION; HYPOTENSION; INCIDENCE; LOW DRUG DOSE; MENTAL DISEASE; METABOLIC DISORDER; MUSCLE STIFFNESS; PATIENT CARE; PERCEPTION DISORDER; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN IRRITATION; TERMINAL CARE; TERMINAL DISEASE; TREMOR;

ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; COUNSELING; DELIRIUM; FAMILY HEALTH; HUMANS; HYPNOTICS AND SEDATIVES; NEOPLASMS; PHYSICAL EXAMINATION;

EID: 2942653036     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216304pm879oa     Document Type: Review

References (70)

1. Meagher DJ. Delirium: optimising management. BMJ 2001; 322: 144-49.
2. Casarett DJ, Inouye SK. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001; 135: 32-40.
3. Ross DD, Alexander CS. Management of common symptoms in terminally ill patients. Constipation, delirium and dyspnea. Am Fam Physician 2001; 64: 1019-26.
4. Ingham JM, Caraceni AT. Delirium. In Berger Am, Portenoy RK, Weissman R eds. Principles and practice of supportive oncology. Philadelphia: Lippincott-Raven Publishers, 1998: 477-95.
5. Cobb JL, Glantz MJ, Nicholas PK, et al. Delirium in patients with cancer at the end of life. Cancer Pract 2000; 8: 172-77.
6. Minagawa H, Uchitomi Y, Yamawaki S, et al. Psychiatric morbidity in terminally ill cancer patients. A prospective study Cancer 1996; 78: 1131-37.
7. McDonald AJD. Delirium. In Tallis R, Fillit H, Brocklehurst JC eds. Brocklehurst's textbook of geriatric medicine and gerontology, 5th ed. Edinburgh: Livingstone, 1998: 685-700.
8. Gallinat J, Moller H, Moser RL, et al. Postoperative delirium: risk factors, prophylaxis and treatment. Anaesthesist 1999; 48: 507-18.
9. Karlsson I. Drugs that induct delirium. Dement Geriatr Cogn Disord 1999; 10: 412-15.
10. American Psychiatric Association. Practice guidelines for the treatment of patient with delirium. Washington DC: American Psychiatric Association, 1999.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association, 1994.
12. Lawlor PG. The panorama of opioid-related cognitive dysfunction in patients with cancer. Cancer 2002; 94: 1836-53.
13. Caraceni A. Delirium in palliative care. Eur J Palliat Care 1995; 2: 62-67.
14. Akechi T, Nakano T, Okamura H, et al. Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol 2001; 31: 188-94.
15. Bruera E, Miller L, McCallion J, et al. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992; 7: 192-95.
16. Morita T, Tei Y, Tsunoda J, Inoue M, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001; 22: 997-1006.
17. Lawlor PG, Gagnon B, Mancini IL, et al. Delirium as a predictor of survival in older patients with advanced cancer. Arch Intern Med 2000; 160: 2866-68.
18. Gagnon P, Allard P, Masse B, DeSerres M. Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 2000; 19: 412-26.
19. Sarhill N, Walsh D, Nelson KA, LeGrand S, Davis MP. Assessment of delirium in advanced cancer: the use of the bedside confusion scale. Am J Hosp Palliat Care 2001; 18: 335-41.
20. Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Cancer 2000; 89: 1145-49.
21. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Managc 1999; 17: 231-39.
22. Dunlop RJ, Campbell CW. Cytokines and advanced cancer. J Pain Symptom Manage 2000; 20: 214-32.
23. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5: 132-48.
24. Brown TM. Drug-induced delirium. Semin Clin Neuropsychiatry 2000; 5: 113-24.
25. Reyes-Ortiz CA, Largo U, Cárdenas JP. Síndrome confusional agudo en un nonagenario hospitalizado. Colombia Médica 1998; 29: 158-61.
26. Cheng C, Roemer-Becuwe C, Pereira J. When midazolam fails. J Pain Symptom Manage 2002; 23: 256-65.
27. Tuma R, DeAngelis LM. Altered mental status in patients with cancer. Arch Neurol 2000; 57: 1727-31.
28. Moss JH, Lanctot KL. Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients. J Am Geriatr Soc 1998; 46: 1020-22.
29. Lipowski ZJ. Update on delirium. Psychiatr Clin North Am 1992; 15: 335-46.
30. Keeley PW, Foster G, Whitelaw L. Hear my song: auditory hallucinations with tramadol hydrochloride. BMJ 2000; 321: 1608.
31. Fountain A. Visual hallucinations: a prevalence study among hospice inpatients. Palliat Med 2001; 15: 19-25.
32. Coyle N, Breitbart W, Weaver S, Portenoy R. Delirium as a contributing factor to crescendo pain: three case reports. J Pain Symptom Manage 1994; 9: 44-47.
33. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43: 183-94.
34. Cherny NI, Coyle N, Foley KM. Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care 1994; 10: 57-70.
35. Fainsinger RL, Tapper M, Bruera E. A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 1993; 9: 4-8.
36. Inouye SK, Foreman MD, Mion LC, et al. Nurses' recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Intern Med 2001; 161: 2467-73.
37. Schuurmans MJ, Duursma SA, Shortridge-Baggett LM. Early recognition of delirium: review of the literature. J Clin Nurs 2001; 10: 721-29.
38. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
39. Lobo A, Saz P, Marcos G, et al. Revalidation and standardization of the Cognition Mini-Exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin (Barc) 1999; 112: 767-74.
40. Lobo A. Screening de trastornos psíquicos en la práctica médica. Zaragoza: Secretariado de Publicaciones, Universidad de Zaragoza, 1987.
41. Breibart W, Rosenfld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13: 128-37.
42. Lawlor PG, Nekolaichuk C, Gagnon B, et al. Clinical utility, factor analysis, and further validation of the Memorial Delirium Assessment Scale in patients with advanced cancer: assessing delirium in advanced cancer. Cancer 2000; 88: 2859-67.
43. Trzepacz P, Baker R, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988; 23: 89-97.
44. Morita T, Tsunoda J, Inoue S, Chihara S, Oka K. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med 2001; 15: 197-206.
45. Indelicato RA, Portenoy RK. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002; 20: 348-52.
46. Fainsinger RL, MacEachern T, Miller MJ, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994; 9: 298-302.
47. Simon L, Jewell N, Brokel J. Management of acute delirium in hospitalized elderly: a process improvement project. J Geriatr Nurs 1997; 18: 1504.
48. Morency CR. Mental status change in the elderly: recognizing and treating delirium. J Prof Nurs 1990; 6: 356-64.
49. Foreman MD, Mion LC, Tryostad L, et al. Standard of practice protocol: acute confusion/delirium. NICHE Faculty. J Geriatr Nurs 1999; 20: 147-52.
50. Driver LC, Bruera E. Delirium. In Driver LC, Bruera E eds. The MD Anderson palliative care handbook. Houston: The University of Texas, 2000; 95-99.
51. Platt MM, Breitbart W, Smith M, et al. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6: 66-67.
52. Mazzocato C, Stiefel F, Buclin, T et al. Psychopharmacology in supportive care of cancer: a review for the clinician. Neuroleptics. Support Care Cancer 2000; 8: 89-97.
53. Breitbart W. Diagnosis and management of delirium in terminally ill. In Bruera E, Portenoy R eds. Topics in palliative care. Volume 5. New York: Oxford University Press, 2001; 303-21.
54. Lee MA, Leng ME, Tiernan EJ. Risperidone: a useful adjunct for behavioural disturbance in primary cerebral tumours. Palliat Med 2001; 15: 255-56.
55. Kiraly SJ, Gibson RE, Ancill RJ, Holliday SG. Risperidone: treatment response in adult and geriatric patients. Int J Psychiatry Med 1998; 28: 255-63.
56. Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L. Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol 1998; 18: 171-72.
57. Sipahimalani A, Masand PS. Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9: 105-107.
58. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43: 175-82.
59. Davis MP, Dickerson ED. Olanzapine: another psychotropic? Am J Hosp Palliat Care 2001; 18: 129-32.
60. Passik SD, Cooper M. Complicated delirium in a cancer patient successfully treated with olanzapine. J Pain Symptom Manage 1999; 17: 219-23.
61. Breibart W, Marotta R, Platt M, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 6: 231-37.
62. Fainsinger RL, Waller A, Bercovici M, et al. A multi-centre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000; 14: 257-65.
63. TREC Collaborative Group. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ 2003; 327: 708-13.
64. Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage 1999; 17: 363-68.
65. Morita T, Otani H, Tsunoda J, et al. Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer 2000; 8: 134-37.
66. Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990; 263: 1097-101.
67. Levkoff SE, Evans DA, Liptzin B, et al. Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992; 152: 334-40.
68. O'Keeffe S, Lavan J. The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc 1997; 45: 174-8.
69. Metitieri T, Bianchetti A, Trabucchi M. Delirium as a predictor of survival in older patients with advanced cancer. Arch Intern Med 2000; 160: 2866-68.
70. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001; 49: 516-22.